Bloodless management of benign prostatic hyperplasia: medical and minimally invasive treatment options

The Aging Male : the Official Journal of the International Society for the Study of the Aging Male
Evangelos LiatsikosJens-Uwe Stolzenburg

Abstract

Benign prostatic hyperplasia (BPH) is a medical condition affecting a wide range of the aging male population resulting in various degrees of lower urinary tract symptoms (LUTS). Today, a variety of medical therapies and minimally invasive BPH treatment modalities are available. Medical therapy includes α(1) blockers, 5()α reductase inhibitors and combination therapy. When these options fail, surgery is indicated. Transurethral resection of the prostate (TURP) is still considered the gold standard surgical treatment for BPH. Nevertheless, numerous minimally invasive treatment alternatives are available that are comparable in effectiveness to TURP, with significantly less morbidity. In this article, current treatment options for BPH are reviewed with respect to their indications, long-term safety and efficacy in relieving BPH related LUTS. The selection of the type of BPH treatment should be based on the physician's experience, patient's co-morbidities as well as the prostate size and clinical disease progression.

References

Oct 22, 1992·The New England Journal of Medicine·G J GormleyJ S Tenover
May 8, 1999·BJU International·S Madersbacher, M Marberger
Nov 24, 1999·European Urology·C R Chapple
May 8, 2001·Journal of Endourology·H BottoP M Lugagne
Dec 17, 2003·Scandinavian Journal of Urology and Nephrology·Fredrik LiedbergInga-Britt Palmqvist
Dec 19, 2003·The New England Journal of Medicine·John D McConnellUNKNOWN Medical Therapy of Prostatic Symptoms (MTOPS) Research Group
Nov 23, 2006·BMJ : British Medical Journal·Christian T BrownMark Emberton
May 4, 2007·European Urology·Peter J GillingMark R Fraundorfer
Oct 19, 2007·Journal of Endourology·Samuel J S GrimsleyPeter H Paterson
Jan 31, 2008·Journal of Huazhong University of Science and Technology. Medical Sciences = Hua Zhong Ke Ji Da Xue Xue Bao. Yi Xue Ying De Wen Ban = Huazhong Keji Daxue Xuebao. Yixue Yingdewen Ban·Jun LüWei Wang
May 24, 2008·The Journal of Urology·Oliver ReichUNKNOWN Urology Section of the Bavarian Working Group for Quality Assurance
Dec 6, 2008·Current Opinion in Urology·Nazareno SuardiFrancesco Montorsi

❮ Previous
Next ❯

Citations

Feb 3, 2018·The Aging Male : the Official Journal of the International Society for the Study of the Aging Male·Mustafa ErkocFatih Altunrende
Jan 31, 2018·The Aging Male : the Official Journal of the International Society for the Study of the Aging Male·Aldo E CalogeroSandro La Vignera
Nov 24, 2018·The Aging Male : the Official Journal of the International Society for the Study of the Aging Male·Mustafa ErkocMuammer Bozkurt
Mar 14, 2020·International Braz J Urol : Official Journal of the Brazilian Society of Urology·Wilson F S Busato
May 14, 2020·The Aging Male : the Official Journal of the International Society for the Study of the Aging Male·Erdal BenliIbrahim Yazici

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.